Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy
Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy - A Prospective Follow-up Study
Sponsor: Chang Gung Memorial Hospital
Listed as NCT03534050, this PHASE2/PHASE3 trial focuses on Glioma of Brain and remains actively recruiting participants. Sponsored by Chang Gung Memorial Hospital, it has been updated 9 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jun 2023 — Jul 2024 [monthly]
Recruiting PHASE2_PHASE3
-
Apr 2021 — Jun 2023 [monthly]
Recruiting PHASE2_PHASE3
▶ Show 4 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Sep 2019 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Mar 2019 — Sep 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2018 — Mar 2019 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chang Gung Memorial Hospital
For direct contact, visit the study record on ClinicalTrials.gov .